hrp0089na1.1 | The clinical relevance of metabolomics; genomic engineering - CRISP-R/Cas9 and its many implications | ESPE2018
hrp0089p2-p216 | GH & IGFs P2 | ESPE2018
hrp0095p1-151 | Pituitary, Neuroendocrinology and Puberty | ESPE2022
Rodanaki Maria , Rask Eva , Lodefalk Maria
hrp0092p2-201 | Growth and Syndromes (to include Turner Syndrome) | ESPE2019
Pankratova Maria , Brovin Dmitriy , Kareva Maria
hrp0089rfc5.3 | Thyroid | ESPE2018
Rodanaki Maria , Lodefalk Maria , AEman Jan
hrp0089p2-p311 | Pituitary, Neuroendocrinology and Puberty P2 | ESPE2018
Rodanaki Maria , Rask Eva , Lodefalk Maria
hrp0094p1-86 | Pituitary A | ESPE2021
Rodanaki Maria , Rask Eva , Lodefalk Maria ,
hrp0095p2-202 | Multisystem Endocrine Disorders | ESPE2022
hrp0092p2-124 | Fat, Metabolism and Obesity | ESPE2019
Kovalenko Tatiana , Larionova Maria
hrp0082s2.2 | Endocrine Cancer Syndromes: An Update | ESPE2014